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ABSTRACT 
Most of the anticancer drugs bind to double-stranded DNA (dsDNA) by intercalative-binding 
mode. Although experimental studies have become available recently, a molecular-level 
understanding of the interactions between the drug and dsDNA that lead to the stability of the 
intercalated drug is lacking. Of particular interest are the modifications of the mechanical 
properties of dsDNA observed in experiments. The latter could affect many biological functions, 
such as DNA transcription and replication. Here we probe, via all-atom molecular dynamics (MD) 
simulations, change in the mechanical properties of intercalated drug–DNA complexes for two 
intercalators, daunomycin and ethidium. We find that, upon drug intercalation, stretch modulus of 
DNA increases significantly, whereas its persistence length and bending modulus decrease. 
Steered MD simulations reveal that it requires higher forces to stretch the intercalated dsDNA 
complexes than the normal dsDNA. Adopting various pulling protocols to study force-induced 
DNA melting, we find that the dissociation of dsDNA becomes difficult in the presence of 
intercalators. The results obtained here provide a plausible mechanism of function of the anticancer 
drugs—i.e., via altering the mechanical properties of DNA. We also discuss long-time 
consequences of using these drugs, which require further in vivo investigations.  
 
I. INTRODUCTION 
The interaction of a small drug molecule with dsDNA is a subject of great current interest.  A 
small-molecule drug can interact with a dsDNA either specifically or non-specifically. There are 
three specific DNA-binding modes—namely, minor groove, major groove and intercalative 
bindings—along with the non-specific electrostatic binding mode.1 In intercalative binding, a drug 
(or part of it) inserts between two consecutive base-pairs of a dsDNA [see Figs. 1(b) and 1(c)]. All 
intercalative drugs have common design principle: the drug consists of phenyl rings arranged in a 
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plane and a positively charged side chain. The phenyl rings intercalate into DNA and are stabilized 
by the π-stacking interactions with the DNA bases, while the side chain interacts electrostatically 
with the negatively charged DNA backbone. Enormous interest in understanding the process of 
drug-intercalation and its effect on DNA mechanics exists because most of the anticancer drugs 
are known to intercalate into DNA. DNA-intercalators are believed to hinder DNA replication and 
transcription,2-4 eventually leading to cell death—thus acting as anticancer drugs. However, 
serious side effects of the intercalating anticancer drugs have been observed due to low selectivity 
towards cancer cells and DNA sequences. It is important to obtain and understand the mechanical 
and biophysical properties of drug–DNA complexes for the design and optimization of new 
anticancer drugs, as these drugs mainly target DNA.5,6  
Over the last two decades, significant progress has been made to experimentally study various 
biophysical processes, such as protein folding/unfolding7,8 and DNA mechanics, 9,10 and enormous 
insight has been gained about the intermediate structures, free-energy landscape, pathways and 
kinetics of conformational transitions—thanks to the advancement in single-molecule force 
spectroscopy (SMFS) techniques.11 More recently, SMFS techniques have been used to study in 
details the kinetics of intercalation and the mechanism of DNA and small-molecules (or proteins) 
interactions along with the possible biological implications.1,12-14 Intercalators have also been used 
as fluorescent probes to unravel structural details about various overstretched conformations of 
DNA.15-17 The overstretching transition of dsDNA15,18 is known to shifts towards higher forces at 
lower intercalator concentration; however at a high enough concentration of intercalator, the 
overstretched state vanishes completely.3,19,20 Some experimental works have demonstrated that 
intercalators increase DNA melting force.19,21,22 Recent SMFS experiments suggest that 
intercalators increase the stretch (or Young’s) modulus of DNA,23,24 whereas the bending rigidity 
and persistence length of dsDNA remain unaffected upon drug intercalation.25,26 Despite these 
experimental studies, there is still controversy about the modifications in elastic properties of 
dsDNA in the presence intercalators.13 These experimental results have also not been studied by 
simulations, except in references.22,23,27 In particular, little seems to be known about the details of 
the effects of small-molecule binding on the functions of dsDNA, such as its dissociation 
mechanics. 
Molecular dynamics (MD) simulation studies have provided valuable insights into various aspects 
of the intercalation process.28,29 Particularly, for an anticancer drug daunomycin,30 the pathways, 
the free energy landscapes and the thermodynamics of intercalation have been studied in great 
details, revealing the formation of a DNA minor-groove-bound intermediate state before a fully 
intercalated state is reached.31,32 For another simple intercalator such as ethidium (also frequently 
used as a fluorescent tag), the changes in the dsDNA structure and dynamics upon intercalation, 
the end-state thermodynamics of intercalation and dsDNA dissociation in presence of the 
intercalator have been investigated.22,33 These studies along with other experimental studies 
revealed that intercalators distort dsDNA structure locally, such as an increase in the base-pair rise 
along with specific changes in the twist and roll parameters, and that intercalation is enthalpically 
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driven, while groove-binding is entropically driven.34 However, despite having important 
implications for biological functions and pharmacology, systematic determination and quantitative 
understanding of the changes in elastic properties of DNA, its dissociation mechanics and 
pathways, and its structure in presence of intercalators are far from complete.  
In this study, we consider two DNA intercalators, daunomycin and ethidium. We have performed 
all-atom equilibrium and nonequilibrium MD simulations in explicit solvent to unravel the 
microscopic mechanics of the intercalated drug–DNA complexes as well as of the normal B-DNA, 
for comparison. The rest of the manuscript is organized as follows. First, molecular modeling 
approach and simulation protocols are described in the Methods section. Then, we discuss and 
compare the equilibrium simulations results of the intercalated drug–DNA complexes and the B-
DNA, followed by those from nonequilibrium simulations. We conclude this article with a 
plausible mechanism of action of the anticancer drugs, possible implications of using it and some 
outlooks. 
II. METHODS 
A. Model Building and Force Field Parameters 
The crystal structure for the complex, daunomycin drug intercalated to dsDNA, was obtained from 
the protein data bank (PDB ID: 1D11). Following the procedure by Mukherjee et al.,31,32 we built 
a dsDNA dodecamer of sequence (GCGCACGTGCGC)2; the intercalation site is present between 
the central C6 and G7 bases (denoted in bold characters in the above sequence). A segment of 5′-
ACG-3′ from the crystal structure was taken that contains a single daunomycin molecule between 
C and G bases. To build the complete structure, this segment was further extended by adding in 
both sides appropriate numbers of base-pairs in the canonical B-form by using the nucleic acid 
builder (NAB) tool.35 A similar procedure was followed to build dsDNA–ethidium complex, 
except the central part, i.e., ethidium intercalated between the two GC base pairs was taken from 
the available crystal structure.36 The same DNA sequence as the DNA–daunomycin complex was 
chosen for better comparison. For a control simulation, a B-DNA, i.e., dsDNA dodecamer of the 
above sequence in the canonical B-form was built by using the NAB tool.35  
The ff14SB37 force field parameters with parmbsc038 correction were used for DNA. The 
molecular models for daunomycin and ethidium were developed following Merz/Kollman 
method.39 First, their geometry optimizations and the ESP charge calculations were done through 
the Gaussian package40 using a 6-31G* basis set. Then, the ANTECHAMBER41 module of 
AMBER was used to obtain the RESP charges on each atom and the GAFF42 atom types. Each 
complex was solvated with TIP3P43 water model using the xleap module of the AMBER17 tools44 
in a large enough rectangular box guaranteeing no image interactions. The box dimensions of the 
solvated B-DNA, dsDNA–daunomycin and dsDNA–ethidium complexes are 7.4×7.4×7.4 nm3, 
8.0×8.0×8.0 nm3 and 8.1×8.3×8.3 nm3, respectively. Appropriate numbers of monovalent ions 
(22 𝑁𝑎+ and 1 𝐶𝑙−) were added in the simulation box ensuring the charge neutrality of the unit 
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shell. Joung/Cheatham45 ion parameters were used to describe the interaction between ions, water 
and DNA. 
B. Equilibrium MD Simulation Protocol 
Periodic boundary condition (PBC) was used for all simulations. Bonds involving hydrogen atoms 
were constrained using the SHAKE46 algorithm that allows using a larger time step of 2 fs for the 
integration of the equations of motion. The temperature of the system was maintained using a 
Langevin thermostat47 with the collision frequency of 5.0 ps-1. The Berendsen weak coupling 
method48 was used to maintain a pressure of 1 atm with a pressure relaxation time constant of 2.0 
ps. The particle mesh Ewald (PME)49 sum was used to compute the long-range electrostatic 
interactions with a real-space cutoff of 10 Å. The van der Waals (vdW) and direct electrostatic 
interactions were truncated at the cutoff. The direct sum non-bonded list was extended to cutoff + 
“nonbond skin” (10 + 2 Å). 
The solvated system with harmonic restraints (force constant of 500 kcal mol-1 Å-2) on the position 
of each solute atom was first subjected to 1000 steps of steepest descent energy minimization, 
followed by 2000 steps of conjugate gradient minimization to remove bad contacts present in the 
initially built systems. Restraints on the solute atoms were sequentially decreased to zero during 
further 4000 steps of energy minimization. The energy minimized system was then slowly heated 
from 10 to 300 K in many steps during the first 21 ps of MD simulation. During this dynamic, the 
solute particles were restrained to their initial positions using harmonic restraints with a force 
constant of 20 kcal mol-1 Å-2. The initial restrained heating and the next first 2 ns equilibration 
simulations were performed in the NPT ensemble to reach the proper density. Subsequently, 200 
ns simulation was run in the NVT ensemble. Simulations were performed using the PMEMD 
module of the AMBER14 package.50 
C. Steered Molecular Dynamics (SMD) Simulation Protocol 
The equilibrated structure of dsDNA–daunomycin (or dsDNA–ethidium) complex from AMBER 
simulation was taken as the starting structure, re-solvated in a rectangular box (the size varies 
depending on the pulling protocol as described in Fig. 2) and added counter ions for charge 
neutralization. This solvated system was subjected to energy minimization and heating protocols 
as described in the previous section, prior to equilibration in NPT ensemble. The temperature of 
the systems was controlled at 300 K by using a Langevin thermostat47 with a collision frequency 
of 5.0 ps-1. 1 atm pressure was maintained using Nose−Hoover Langevin barostat (see section 7.5.2 
of NAMD user’s guide, http://www.ks.uiuc.edu/Research/namd/2.10b1/ug.pdf) with piston period 
of 0.2 ps and damping time constant of 0.05 ps. PME49 was used to compute the long-range 
electrostatic interactions with a real-space cutoff of 12 Å. The vdW interaction was truncated at a 
cutoff of 12 Å by using a switch function (switchdist = 10 Å). PBC and a time step of 2 fs (enabled 
via SHAKE)46 were used. All equilibrium and subsequent SMD simulations were performed using 
the NAMD-2.10 package.51 
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For the SMD simulations depending on the pulling protocol as described in Fig. 2, some atoms of 
the dsDNA were fixed, and some other atoms of the dsDNA were pulled. In a SMD simulation,52 
the atom being pulled (called SMD atom) is connected via a spring (here, force constant 𝑘 = 10 
kcal mol−1 Å−2) to a virtual atom, which is moved with a constant velocity 𝑉 in a direction ?⃗?  that 
depends on the pulling protocol (see the direction of the arrow in Fig. 2). The effective SMD 
potential, 𝑈, is given by 𝑈(𝑟 ) =
1
2
𝑘[𝑉𝑡 − (𝑟 − 𝑟0⃗⃗  ⃗) ∙ ?⃗? ]
2, where 𝑟  and 𝑟0⃗⃗  ⃗ are the positions of the 
atom being pulled at time 𝑡 and at the initial time, respectively. And the force, 𝐹 , on the pulled 
atom is calculated by: 
𝐹 = −∇⃗ 𝑈 = 𝑘[𝑉𝑡 − (𝑟 − 𝑟0⃗⃗  ⃗) ∙ ?⃗? ]?⃗? .                                                                                                          (1)    
In our previous work,53 we used a similar SMD protocol to study protein–protein binding in the 
presence and absence of dendrimer. All the SMD simulations performed in this work add to a total 
simulated time of ~5.5 μs for systems containing ≥ 60661 atoms. At a pulling velocity 𝑉 = 1 Å/ns, 
individual SMD simulations for the SE, OS3, OS5, EU and MU protocols (see Fig. 2) were 
performed up to 40 ns, 100 ns, 100 ns, 150 ns and 60 ns, respectively. For the SE pulling protocol, 
individual SMD simulations at 𝑉 = 0.2 Å/ns and 𝑉 = 0.05 Å/ns were performed up to 200 ns and 
800 ns, respectively. For the MU protocol, each SMD simulation at 𝑉 = 0.2 Å/ns was performed 
up to 270 ns.   
D. Data Analysis 
All the analyses were done by using in-house codes and the AMBER17 tools.44 Images were 
rendered using the VMD software.54  
Curves+ software55 was used to calculate the helix axis and various  inter base pair parameters of 
dsDNA, which include the three distances (shift, slide, and rise) and three angles (twist, roll, and 
tilt) that completely describe successive base pair planes. The distance, 𝑙, between centers of 
successive base pairs in a step is given by 𝑙 = √(𝑠ℎ𝑖𝑓𝑡)2 + (𝑠𝑙𝑖𝑑𝑒)2 + (𝑟𝑖𝑠𝑒)2 .56 These data were 
used to calculate the end-to-end distance, contour length, and the local tangent vectors.  
The extension for each pulling protocol (see Fig. 2) is defined as 𝑉𝑡, i.e., is the distance traveled 
by the virtual atom which is connected via a spring to the SMD atom. 
The total number of hydrogen bonds, NHB, is calculated by summing the hydrogen bonds present 
for each DNA base pair. A hydrogen bond is counted if the distance between a donor atom (Dn) 
and an acceptor atom (Ac) is ≤ 3 Å and the Dn–H⋯Ac angle is ≤ 135°. 
The average cumulative work done 〈𝑊〉 for taking the DNA from its equilibrium configuration to 
a deformed state is given by: 
〈𝑊〉 = 〈∫ 𝑑𝑡
𝑡
0
?⃗? ∙ 𝐹 〉 ,                                                                                                                                    (2) 
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where 〈∙〉 represents the average over four different simulation runs, and all other symbols are the 
same as those in Eq. (1). The estimated error in the work at a given extension is the standard 
deviation of four different simulation runs at a pulling velocity 𝑉 = 1 Å/ns, as shown for the 
different cases in Figs. 3–8. 
III. RESULTS 
A. DNA mechanics and the effect of drug intercalation on various structural and elastic 
properties of DNA from equilibrium simulations 
The mechanical properties of dsDNA can be inferred by studying its various structural properties. 
Two of the important phenomenological parameters that describe DNA elasticity are the stretch 
and bending moduli. Here, we calculate these two quantities. We also calculate structural 
properties such as end-to-end distance, contour length, and persistence length of the bare B-DNA 
[see Fig. 1(a)] and DNA in the presence of an intercalated daunomycin [see Fig. 1(b)] or ethidium 
[see Fig. 1(c)]. All the results are summarized in Table I. 
End-to-end distance, 𝐿𝑑, of DNA is defined as the distance between the centers-of-mass of the two 
terminal base pairs of the dsDNA. We see ~4 Å increase in 𝐿𝑑 for both the intercalated DNA 
complexes compared to that for the bare B-DNA. Contour length, 𝐿0, is calculated by summing 
over the distance (𝑙𝑖) between each base pair step and it is given by 𝐿0 = ∑ 𝑙𝑖
𝑁−1
𝑖=1 , where 𝑁 is the 
total number of base pairs. Like 𝐿𝑑, we observe that 𝐿0 increases for the drug intercalated DNA 
complexes. These increases in 𝐿𝑑 and 𝐿0 upon drug-intercalation is due to an increase in the rise 
between the two base pairs that accommodate the intercalated drug, as shown in Fig. S1(a) in the 
supplementary material (SM).  
Stretch modulus, γ, is obtained from the contour length distribution as described below, following 
our earlier works.57,58 In equilibrium, the instantaneous contour length, 𝐿, of DNA fluctuates 
around its mean value 𝐿0. Within the elastic rod model, the restoring force, 𝐹, generated due to the 
instantaneous fluctuation in the contour length, 𝐿 − 𝐿0,  is proportional to 𝐿 − 𝐿0, and it is given 
by 𝐹 = −γ(𝐿 − 𝐿0)/𝐿0. The energy function, 𝐸(𝐿), due to 𝐹 is obtained by integrating 𝐹 w.r.t. 𝐿 
and is given by 𝐸(𝐿) = γ(𝐿 − 𝐿0)
2/2𝐿0. Then, the probability distribution for the contour length, 
𝑃(𝐿), is obtained by putting the energy term, 𝐸(𝐿), in the Boltzmann’s formula and normalizing 
it. 𝑃(𝐿) is a Gaussian distribution and is given by: 
𝑃(𝐿) = √
𝛽𝛾
2𝜋𝐿0
𝑒𝑥𝑝 [−
𝛽𝛾𝐿0
2
(
𝐿
𝐿0
− 1)
2
]                                                                                               (3) 
⇒ ln𝑃(𝐿) = −
𝛽𝛾𝐿0
2
(
𝐿
𝐿0
− 1)
2
+
1
2
ln
𝛽𝛾
2𝜋𝐿0
,                                                                                       (4) 
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where 𝛽 = 1 𝑘𝐵𝑇⁄ ; 𝑘𝐵 is the Boltzmann constant, and 𝑇 is the temperature. 𝑃(𝐿) obtained from 
our simulation (data points) fits well with Eq. (3) (lines) for all the complexes, as shown in Fig. 
1(d) [left panel]. γ is then obtained from the slope in Fig. 1(d) [right] by fitting the simulation data 
using Eq. (4). The average stretch moduli of all the complexes and the associated errors are 
provided in Table I. For the bare B-DNA, we find that the stretch modulus γ is 1167 pN, which is 
in quantitative agreement with the values estimated in previous experiments as well as our earlier 
simulations.57-60 γ of the DNA–daunomycin complex is 1535 pN and is 32% higher than that of 
the bare DNA. For the DNA–ethidium complex, we find that the stretch modulus of DNA is even 
higher (2119 pN), which is 81% higher than the value obtained for the bare DNA. The increase in 
γ of DNA upon a drug intercalation might be due to the enhancement in the π-π stacking interaction 
among the base pairs near to the intercalation site, because of the interaction between the bases 
and the phenyl rings of the intercalator.  
Bending modulus, κ, (and persistence length, 𝑙𝑃 = 𝛽𝜅) can be determined from the bending angle 
distribution as follows. To calculate the bending angle (θ) of DNA, we define two tangent vectors 
by joining the centers-of-mass of two consecutive terminal base pairs for either ends of dsDNA, 
and θ is obtained by taking the cosine inverse of the dot product of these two vectors. The 
probability distribution for the bending angle, 𝑃(𝜃), obtained from the simulation for each 
complex is plotted in Fig. 1(e) [left]. 𝑃(𝜃) for small fluctuations in θ can be approximated as 
Gaussian in nature,61 and is given by:57,58 
𝑃(𝜃) = √
𝛽𝜅
2𝜋𝐿0
𝑒𝑥𝑝 [−
𝛽𝜅
2𝐿0
𝜃2]                                                                                                                (5) 
⇒ ln𝑃(𝜃) = −
𝑙𝑃
𝐿0
(1 − cos 𝜃) +
1
2
ln
𝛽𝜅
2𝜋𝐿0
.                                                                                          (6) 
Persistence length, 𝑙𝑃, and bending modulus (𝜅 = 𝑙𝑃𝑘𝐵𝑇) are obtained from the slope of 
(1 − cos 𝜃) versus ln 𝑃(𝜃) plot in Fig. 1(e) [right] by a linear fit of simulation data to Eq (6). The 
average bending moduli and persistence lengths of all the complexes and the associated errors are 
given in Table I. In contrast to the behavior observed for stretch modulus, we find that 𝑙𝑃 (and 
hence κ) of dsDNA decreases by 16% and 41% in the presence of daunomycin and ethidium, 
respectively. This decrease in 𝑙𝑃 (and κ) might be due to the local unwinding of the DNA double 
helix structure near to the intercalation site [see Fig. S1(b) in the SM], which facilitates large 
fluctuation in the bending angle 𝜃. 
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FIG. 1. Comparison of structure and elastic properties of the B-DNA and the intercalated drug–
DNA complexes from equilibrium simulations. (a) Equilibrated structure of the B-DNA: One 
strand of the dsDNA is represented in purple color, while another strand is depicted in green color. 
(b) Equilibrated structure of the DNA–daunomycin complex: The drug daunomycin (color: blue) 
intercalated between the middle two base-pairs of the dsDNA is shown in VDW representation. 
(c) Equilibrated structure of the DNA–ethidium complex, where the drug ethidium is depicted in 
orange color. Water molecules and ions are not shown in (a), (b) and (c) for clarity. Stretch 
modulus, γ, and persistence length, 𝑙𝑃, (as well as bending rigidity κ) for each system are calculated 
from the normalized probability distributions of DNA contour length (d) and bending angle (e), 
respectively. See the text for details. The distributions for each system are obtained from the last 
50 ns of 200 ns long simulation. 
  
TABLE I. The structural and elastic properties of dsDNA in the presence and absence intercalated 
drugs calculated from equilibrium simulations data and their comparisons with experiments. The 
errors in 𝐿𝑑 and 𝐿0 are the standard deviations of the respective data points obtained from the last 
50 ns of 200 ns long simulation. The errors in γ, κ and 𝑙𝑃 are the propagation errors in 
multiplications of 𝐿0 with the respective slopes (see Fig. 1). The error in the slope is the standard 
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error of the estimate in linear regression. The experimental values for the bare DNA are taken from 
the study by Gross et al.60 
System End-to-end 
distance, 𝐿𝑑, 
(Å) 
Contour 
length, 𝐿0, 
(Å) 
Stretch 
modulus, γ, 
(pN) 
Bending 
modulus, κ, 
(pN∙nm2) 
Persistence 
length, 𝑙𝑃, 
(nm) 
B-DNA 35.38±1.07 38.63±0.88 1166.9±72.3 219.42±8.58 52.97±2.07 
DNA + 
daunomycin 
39.06±1.00 41.92±0.82 1534.6±88.5 183.58±8.23 44.32±1.99 
DNA + 
ethidium 
39.35±1.05 42.18±0.79 2118.6±102.3 128.19±7.32 30.97±1.77 
bare DNA 
(experiment) 
— 28500±60 1450±50 162±12 39±3 
 
The “local” effect of an intercalator on the structural and elastic properties of DNA   
As can be seen from Fig. S1 in the SM that an intercalator affects the DNA base-stacking 
interactions maximum up to 3 base pairs from the intercalation site. To understand what is the 
extent to which the intercalators locally modify various properties of DNA, we consider the middle 
6 base-pairs of the DNA duplex (denoted hereafter as the half-length DNA). The structural and 
elastic properties of the half-length DNA are calculated by following the same methods as 
discussed for the full-length DNA. The specific details and analyses for the half-length DNA for 
all the three systems are presented in Fig. S2 in the SM. The structural and elastic parameters of 
the half-length DNA for all the three systems are provided in Table II. We find 54% and 86% 
increases in the stretch modulus of the half-length DNA in the presence of daunomycin and 
ethidium, respectively. In contrast, the persistence lengths (and hence the bending modulus) of the 
half-length DNA for the DNA–daunomycin and DNA–ethidium complexes decrease by 32% and 
38%, respectively. These results are in accord with the results for the full-length DNA complexes. 
As expected, we find that the effect of an intercalator on the structural and mechanical properties 
of DNA is more pronounced in the vicinity of an intercalated drug. 
 
TABLE II. The structural and elastic properties of the middle 6 base pairs of dsDNA in the 
presence and absence of intercalated drugs calculated from equilibrium simulations data. The 
errors in 𝐿𝑑 and 𝐿0 are the standard deviations of the respective data points obtained from the last 
50 ns of 200 ns long simulation. The errors in γ, κ and 𝑙𝑃 are the propagation errors in 
multiplications of 𝐿0 with the respective slopes (see Fig. S2 in the SM). The error in the slope is 
the standard error of the estimate in linear regression. 
System End-to-end 
distance, 𝐿𝑑, 
(Å) 
Contour length, 
𝐿0, (Å) 
Stretching 
modulus, γ, 
(pN) 
Bending 
modulus, κ, 
(pN∙nm2) 
Persistence 
length, 𝑙𝑃, 
(nm) 
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B-DNA 16.06±0.65 17.52±0.66 880.5±73.5 252.09±17.93 60.86±4.33 
DNA + 
daunomycin 
19.75±0.51 20.68±0.57 1359.9±108.0 171.16±9.22 41.32±2.23 
DNA + 
ethidium 
19.61±0.93 21.01±0.57 1639.8±110.4 155.99±8.44 37.66±2.04 
 
B. DNA mechanics and the effect of drug intercalation on it from SMD simulations 
Most of the biological processes in the cell operate at far-from-equilibrium, with the help of 
mechanical forces generated consuming chemical energy. Specifically, in DNA transcription and 
replication processes, a dsDNA must be partially melted/dissociated for read-out of the genetic 
codes. DNA intercalators might hamper these processes as intercalators modify the elastic 
properties of dsDNA, as shown in the previous section. Besides, nonlinear effects become 
prominent in presence of higher stretching forces and it is interesting to see how that affects the 
mechanics of the intercalated drug–DNA complexes. Motivated by these questions, we perform 
constant velocity pulling simulations for the bare dsDNA and the DNA intercalated complexes by 
using the SMD simulation protocol (described in the Methods section) for five different pulling 
geometries as depicted in Fig. 2. We discuss and compare below the results for the B-DNA with 
the DNA–daunomycin complex for each pulling geometry, followed by the results for the DNA–
ethidium complex for two different pulling geometries.    
 
 
 
 
 
 
FIG. 2. Various constant velocity pulling simulation protocols for the daunomycin intercalated 
dsDNA dodecamer. (a) The same end (SE) pulling protocol: We fix one end of each DNA strand 
those are present on the same side and pull the opposite side ends of both strands along the long 
axis of the DNA. The representation and color coding for the DNA–daunomycin complex is the 
same as described in Fig. 1. The fixed atoms are shown as red circles. The SMD atoms, connected 
via a spring to a virtual atom that is being pulled with velocity 𝑉, are depicted as black circles. The 
arrow represents the direction of pulling. (b) The OS3 pulling protocol: We fix 3′-end of one strand 
and pull another strand’s 3′-end along the long axis of DNA. (c) The OS5 pulling protocol: 5′-end 
of one strand is fixed, and another strand’s 5′-end is pulled along the long axis of DNA. (d) The 
end-unzipping (EU) protocol: We fix 3′-end of one strand and pull 5′-end of another strand but in 
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a direction perpendicular to the long axis of DNA. (e) The mid-unzipping (MU) protocol: The 
middle backbone phosphorus atom of one DNA strand is fixed, while the central backbone 
phosphorus atom of another strand is pulled in a direction perpendicular to the long axis of DNA. 
Note that while the base-pairs are sheared for the pulling protocols used in (a), (b) and (c), for the 
‘tear mode’ protocols adopted in (d) and (e) the base-pairs are unzipped one by one. 
1. DNA stretching by the SE pulling protocol  
The pulling geometry for the SE pulling protocol is described in Fig. 2(a). Fig. 3 (left) shows the 
force–extension profile for the DNA–daunomycin complex. For comparison, we have also shown 
the force–extension profile for the bare B-DNA in the same plot. For the DNA–daunomycin 
complex, we observe that the stretching force 𝐹 [defined in  Eq. (1)] increases linearly up to an 
extension of 10 Å (the first elastic regime), followed by a plateau region for 10–25 Å where 𝐹 
merely increases (the overstretching transition), and a sharp increase in 𝐹 after 25 Å (the second 
elastic regime). This force–extension profile is qualitatively very similar to the bare B-DNA as 
shown in Fig. 3. Presence of such three different force regimes in the DNA force–extension 
behavior has also been found in earlier experimental18 and simulation62,63 studies. Note that 𝐹 for 
the intercalated complex is found to be more than that for the B-DNA over the entire range of 
extensions. In Fig. 3 (right), we show the instantaneous snapshots of the DNA–daunomycin 
complex at various extensions. We see that the DNA elongates while its two strands unwind up to 
an extension of 25 Å (see snapshots i–v in Fig. 3). Beyond that extension, the DNA backbones are 
stretched (see snapshots vi–viii in Fig. 3) giving rise to the sharp increase in 𝐹. The snapshots 
show that many of the DNA base pairs melt during this process. To quantify this, we have 
calculated the total number of hydrogen bonds, NHB, as DNA is pulled (see the Methods for the 
definition). NHB versus extension plot shows that all the base pairs remain intact up to the extension 
of 15 Å; then the base pairs gradually melt (see Fig. 3). We find that at very high extension (40 
Å), NHB for the DNA–daunomycin complex is more than that for the B-DNA—many base pairs 
present nearer to the intercalator remain intact. Surprisingly, daunomycin remains intercalated, 
even after significant deformations of dsDNA structure (see snapshot viii in Fig. 3). This is due to 
the strong π-π interaction between the phenyl rings of the intercalator and the enclosing DNA base 
pairs. We also calculate the average cumulative work done 〈𝑊〉 [see Eq. (2)] for stretching dsDNA 
from its equilibrium configuration and find that 〈𝑊〉 for the DNA–daunomycin complex lies above 
that for the B-DNA for all extensions, except the initial 10 Å elongations for which both curves 
overlap (Fig. 3). So, it is much harder to stretch the intercalated drug–DNA complex compared to 
the B-DNA. This observation is in accordance with our finding that the stretch modulus of dsDNA 
significantly increases upon drug intercalation (see Table I). 
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FIG. 3. SMD simulation results for the SE pulling protocol as described in Fig. 2(a) for 𝑉 = 1 Å/ns. 
[left] From top to bottom: Stretching forces, the total number of hydrogen bonds (𝑁𝐻𝐵) involved 
in forming the DNA base pairs and the average cumulative work, 〈𝑊〉, at various DNA-extensions 
for the DNA–daunomycin complex, and their comparisons with the B-DNA results. The associated 
error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin complex and the B-DNA are 
shown in brown and cyan colors, respectively. [right] Snapshots (i–viii) represent the DNA–
daunomycin complex at various DNA-extensions as pointed in the force–extension plot. The 
representation and color coding are the same as described in Fig. 1. 
2. DNA shearing by the OS3 pulling protocol  
The OS3 pulling protocol is described in Fig. 2(b), and all the results are summarized in Fig. 4. 
We see from the force–extension plot that 𝐹 initially increases linearly up to 15 Å followed by a 
force-plateau region for 15–37 Å. Then 𝐹 again increases linearly for the extensions of 37–62 Å, 
and it finally decreases to zero with a sharp jump at 62 Å. From snapshots i–iii in Fig. 4 for the 
DNA–daunomycin complex at various extensions, we find that the dsDNA elongates while its two 
strands unwind up to the extension of 37 Å. After complete unwinding, the dsDNA elongates 
further where its backbones are stretched, and its base pairs are sheared. The dsDNA forms a 
ladder-like structure for this intermediate-range of extensions (see snapshots iv–v in Fig. 4), where 
most of its base pairs remain intact as evident from the NHB versus extension plot (Fig. 4). This is 
the “B-to-S” transition—a dsDNA present in the B-form when overstretched goes to an extended 
conformation called S-DNA15,18—that has been confirmed in both experiments16,64,65 and 
simulations.63,66 Here, we find that the intercalated drug–DNA complex adapts S-DNA like 
structure when pulled from the 3′-end of the DNA. Unlike the gradual decrease of NHB as for the 
SE pulling protocol, NHB decreases slightly from its initial value up to the extension of 62 Å. After 
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that extension, NHB sharply drops down to zero representing melting of most of the base pairs 
(snapshots vi–vii in Fig. 4), which eventually leads to complete separation of the two DNA strands 
(snapshot viii in Fig. 4). So, the force peak observed ~62 Å is mainly due to the tension build-up 
in the hydrogen-bonded base pairs. The rupture force, i.e., the maximum force required to separate 
the two strands is 980 pN for the B-DNA, whereas it is 1200 pN for the DNA–daunomycin 
complex. We find that, for all extensions, the average cumulative work 〈𝑊〉 for the intercalated 
complex is more than that for the B-DNA. 〈𝑊〉 for the complete separation of the two DNA strands 
for the drug intercalated complex is 37 kcal/mol more than that of the bare B-DNA. So, it is 
difficult to melt a dsDNA in the presence of intercalators by shearing it. We also observe that the 
base pairs enclosing the intercalator break at the end (snapshots vii–viii in Fig. 4). This fact 
supports the finding that the strong π-π stacking interaction between the intercalator and the 
enclosing DNA base pairs is the cause for the enhanced stability of the intercalated complex, as 
discussed for the SE pulling protocol. 
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FIG. 4. SMD simulation results for the OS3 pulling protocol as described in Fig. 2(b) for 𝑉 = 1 
Å/ns. 𝐹, 𝑁𝐻𝐵 and 〈𝑊〉 at various extensions for the DNA–daunomycin complex and the bare B-
DNA are plotted. The associated error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin 
complex and the B-DNA are shown in brown and cyan colors, respectively. Snapshots (i–viii) 
represent the DNA–daunomycin complex at various DNA-extensions as pointed in the force–
extension plot. The representation and color-coding in each snapshot are the same as described in 
Fig. 1. 
3. DNA shearing by the OS5 pulling protocol  
Here, we pull the DNA from its 5′-end. This pulling protocol is described in Fig. 2(c), and all the 
results are summarized in Fig. 5. As in the OS3 pulling protocol, we find similar force–extension 
behavior. The force initially increases linearly up to 15 Å. There is a force plateau region for 
extensions of 15–37 Å followed by a linear increase in 𝐹 up to ~60 Å; finally, 𝐹 drops down to 
zero suddenly. But, the rupture forces for the B-DNA (575 pN) and the DNA–daunomycin 
complex (840 pN) obtained in this protocol are much less than the corresponding values for the 
OS3 pulling protocol. This can be understood by looking at the NHB plot and the snapshots at 
various extensions (see Fig. 5). NHB only remain constant up to 20 Å, and it decreases smoothly to 
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zero over the extensions range of 20–60 Å. So, the base pairs melt gradually as the DNA elongates. 
This contrasts with the trend observed for the OS3 pulling protocol, in which most base pairs 
remain intact up to 60 Å balancing the tension. We find, here, no observation of any ladder-like S-
DNA structure for either the intercalated complex (see snapshots ii–vi in Fig. 5) or the B-DNA. 
As in earlier experimental67 and simulation63 studies of force-induced DNA melting, we also find 
no signature of any transformation from the B-DNA to the S-DNA conformation by pulling the B-
DNA from its 5′-end, whereas such a “B-to-S” transition was found when pulled from its 3′-end. 
As for the OS3 pulling protocol, the base pairs near to the intercalator breaks at the end, resulting 
in separation of the two DNA strands (snapshots vi–viii in Fig. 5). The average cumulative work 
〈𝑊〉 for the complete separation of the two strands of the DNA–daunomycin complex is 46 
kcal/mol more than that of the B-DNA. We find that, for this protocol also, intercalator make it 
harder to dissociate a dsDNA by shearing it.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 5. SMD simulation results for the OS5 pulling protocol as described in Fig. 2(c) for 𝑉 = 1 
Å/ns. 𝐹, 𝑁𝐻𝐵 and 〈𝑊〉 at various extensions for the DNA–daunomycin complex and the bare B-
DNA are plotted. The associated error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin 
complex and the B-DNA are shown in brown and cyan colors, respectively. Snapshots (i–viii) 
represent the DNA–daunomycin complex at various DNA-extensions as pointed in the force–
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extension plot. The representation and color-coding in each snapshot are the same as described in 
Fig. 1. 
4. DNA tearing by unzipping it from one end (EU)  
We unzip the dsDNA to get an idea about the length, i.e., the number of bases from the intercalation 
site up to which the base pairs are more stabilized due to the additional stacking interaction with 
the intercalator, apart from the usual intra-base-pair hydrogen bonds and base-base stacking 
interactions. The pulling geometry for the EU protocol is described in Fig. 2(d), and all the results 
are summarized in Fig. 6. The force–extension plot is very different from those discussed before, 
showing a sawtooth pattern. There are many force (𝐹)-peaks of ~250 pN, each corresponding to 
the breaking of a base pair. This is clear from the stepwise decrease in the NHB as a function of the 
extension (see also the instantaneous snapshots i–vi in Fig. 6). Comparing the unzipping forces for 
the B-DNA and the DNA–daunomycin complex, we find that the 𝐹-peaks for the latter is higher 
than the former, except for the first three terminal-base-pairs. The 𝐹-peaks are similar for breaking 
the first three terminal-base-pairs of both the complexes. Also, from the average cumulative work 
〈𝑊〉 plot in Fig. 6, we see that 〈𝑊〉 for the intercalated complex is more than that for the B-DNA 
only after extension of 37 Å; otherwise it is the same for both. We find that, for the complete 
separation of the two DNA strands, 〈𝑊〉 for the intercalated complex is 44 kcal/mol more than that 
for the B-DNA. Thus, intercalator helps in stabilizing the base pairing and base-base stacking 
interactions strengths up to three bases far away from the intercalation site.   
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FIG. 6. SMD simulation results for the EU protocol as described in Fig. 2(d) for 𝑉 = 1 Å/ns. 𝐹, 
𝑁𝐻𝐵 and 〈𝑊〉 at various extensions for the DNA–daunomycin complex and the bare B-DNA are 
plotted. The associated error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin complex 
and the B-DNA are shown in brown and cyan colors, respectively. Snapshots (i–vi) represent the 
DNA–daunomycin complex at various DNA-extensions as pointed in the force–extension plot. 
The representation and color-coding in each snapshot are the same as described in Fig. 1.   
5. DNA tearing by unzipping it from the middle (MU)  
The dsDNA structure and energetics in the vicinity of an intercalated drug are affected the most, 
as we have seen in the above discussion. To directly probe these, we pull the two DNA strands 
from its middle. The pulling geometry for the MU protocol is described in Fig. 2(e), and all the 
results are summarized in Fig. 7. The unzipping force, 𝐹, initially increases linearly with a peak at 
the extension of 5 Å. Then 𝐹 drop down and fluctuates between 100–300 pN. It finally becomes 
zero after the extension of 50 Å, representing the complete separation of the two DNA strands. 
The peak forces for the B-DNA and the DNA–daunomycin are 640 pN and 1000 pN, respectively. 
The force peak corresponds to the simultaneous breaking of the two middle base pairs (see 
snapshot i in Fig. 7). This is clear from the drop in NHB at an extension of 5 Å in Fig. 7. NHB then 
slowly decreases as the extension increases, with a final rapid drop to zero in between 45–50 Å. 
The force–extension plots for the B-DNA and the intercalated complex almost lie on top of each 
other for all extensions, except for 0–14 Å. This shows that once the nearby base pairs on either 
side of the intercalator are broken, the effect of the intercalator is minimal (see the snapshots in 
Fig. 7). The average cumulative work 〈𝑊〉 for the complete separation of the two strands of the 
drug intercalated complex is 52 kcal/mol more than that for the bare B-DNA. Note that for this 
protocol 〈𝑊〉s for the complete separation of the B-DNA and the intercalated complex are the 
lowest among the respective values for all the different pulling protocols.  
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FIG. 7. SMD simulation results for the MU protocol as described in Fig. 2(e) for 𝑉 = 1 Å/ns. 𝐹, 
𝑁𝐻𝐵 and 〈𝑊〉 at various extensions for the DNA–daunomycin complex and the bare B-DNA are 
plotted. The associated error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin complex 
and the B-DNA are shown in brown and cyan colors, respectively. Snapshots (i–vi) represent the 
DNA–daunomycin complex at various DNA-extensions as pointed in the force–extension plot. 
The representation and color-coding in each snapshot are the same as described in Fig. 1.  
6. DNA shearing and tearing in the presence of ethidium intercalator 
To check the effect of ethidium on DNA mechanics, we have also performed SMD simulations for 
two different pulling protocols: the OS3 pulling and the MU. We choose these two protocols as 
the cumulative works, 〈𝑊〉s, for the complete separation of two strands of the B-DNA are found 
to be the maximum and minimum for the OS3 pulling and the MU protocols, respectively. The 
OS3 pulling and the MU protocols are described in Figs. 2(b) and 2(e), respectively. As shown in 
Fig. 8(a), we observe similar shearing force (and NHB) versus extension behavior(s) for the OS3 
pulling protocol, as in the case of DNA–daunomycin complex (see Fig. 4). The rupture force for 
the DNA–ethidium complex is 1240 pN. This is comparable to the rupture force for the DNA–
daunomycin complex (1200 pN) but larger than that for the bare B-DNA (980 pN). The average 
cumulative work 〈𝑊〉 for the complete separation of the two DNA strands of the DNA–ethidium 
complex is 345 kcal/mol. This work is more than the work required for the complete dissociation 
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of the bare B-DNA (323 kcal/mol) but lower than the same for the DNA–daunomycin complex 
which is 360 kcal/mol. As for the B-DNA and the DNA–daunomycin complex in case of the OS3 
pulling protocol, we also observe a ladder-like S-DNA conformation for the DNA–ethidium 
complex, which can be seen from the instantaneous snapshots iii–vi shown in Fig. S3 in the SM. 
For the MU protocol also, as for the DNA–daunomycin (Fig. 7), we observe similar tearing force 
(and NHB) versus extension behavior(s) for the DNA–ethidium as shown in Fig. 8(b). The 
instantaneous snapshots at various extensions are provided in Fig. S4 in the SM. Although the peak 
force for the DNA–ethidium complex (850 pN) is more than that for the B-DNA (640 pN), it is 
much less than the peak force for the DNA–daunomycin complex (1000 pN). 〈𝑊〉 for the complete 
separation of the two strands of the DNA–ethidium complex is 172 kcal/mol. When compared to 
〈𝑊〉 for the complete dissociation of the B-DNA, the total work done for the DNA–ethidium 
complex is only 8 kcal/mol more, while the same for the DNA–daunomycin complex is 52 
kcal/mol higher. Therefore, the intercalation of ethidium strengthens the dsDNA complex as we 
observe from both the pulling protocols, though the effect is less compared to daunomycin 
intercalation. 
FIG. 8. SMD simulation results at 𝑉 = 1 Å/ns for the DNA–ethidium complex [Fig. 1(c)], and their 
comparisons with the B-DNA results. From top to bottom: comparison of forces, 𝑁𝐻𝐵s and 〈𝑊〉s 
between the DNA–ethidium complex and the B-DNA for the OS3 pulling (a) and the MU (b) 
protocols. The OS3 pulling and the MU protocols are described in Figs. 2(b) and 2(e), respectively. 
The associated error bars in the calculations of 〈𝑊〉s for the DNA–daunomycin complex and the 
B-DNA are shown in brown and cyan colors, respectively. The instantaneous snapshots at various 
extension as marked in the force–extension plots for the OS3 pulling and the MU protocols are 
shown in Figs. S3 and S4 in the SM, respectively.  
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IV. DISCUSSION 
The total work done, 〈𝑊〉, for the B-DNA melting by the OS3 pulling, OS5 pulling, EU and MU 
protocols are 323, 247, 195 and 164 kcal/mol, respectively. 〈𝑊〉 for melting the DNA–daunomycin 
complex by the OS3 pulling, OS5 pulling, EU and MU protocols, respectively are 360, 294, 239 
and 216 kcal/mol, while the same for melting the DNA–ethidium complex by the OS3 pulling and 
MU protocols are 345 and 172 kcal/mol, respectively. We see that 〈𝑊〉 very much depends on the 
pulling protocol. For dsDNA melting in case of each of the three complexes, 〈𝑊〉 is the lowest for 
the MU protocol, whereas it is the highest for the OS3 pulling protocol. Note that if the dsDNA 
complex is separated in truly equilibrium manner, then the free energy or the reversible 〈𝑊〉 for 
separating the two DNA strands should be equal for all the pulling protocols. This pulling protocol 
dependence of 〈𝑊〉 can be rationalized by considering the additional contribution to the free energy 
due to the dissipative forces coming from the hydrogen-bonding friction.68 Depending on the 
pulling protocol the intra-base-pair hydrogen bonds are broken apart by either shearing or tearing 
the dsDNA base pairs, and this can contribute to the total dissipative work differently. As we have 
discussed, base-pair-shearing events are seen for the OS3 and the OS5 pulling protocols, whereas 
base-pair-tearing events are observed for the EU and the MU protocols. Evidently, 〈𝑊〉 is larger 
for the former two protocols than the latter two protocols. Therefore, friction or dissipation is much 
less for the tearing than the shearing of the DNA base pairs. 
Note that the pulling force 𝐹 and hence 〈𝑊〉 for the dissociation of dsDNA also depend on the 
pulling velocity 𝑉.69 To check whether the conclusions remain unaltered by changing 𝑉, we 
compare 〈𝑊〉–extension behavior for the B-DNA and the DNA–daunomycin complex when pulled 
via the SE stretching [Fig. 9(a)] and the MU [Fig. 9(b)] protocols for two different pulling 
velocities. For each of the two pulling protocols, we find that the absolute value of the work done 
for a given complex at a given DNA-extension depends very much on the pulling velocity 𝑉 and 
it decreases by lowering 𝑉. The magnitude of this decrease in the work done by lowering the 
pulling velocity also depends on the pulling protocol. Interestingly, we find almost similar 
〈𝑊〉–extension profile for the DNA–daunomycin complex for the SE pulling protocol, even by 
lowering 𝑉 from 0.2 Å/ns to 0.05 Å/ns [see Fig. 9(a)]. This means that for the SE pulling protocol, 
the deformation becomes reversible for 𝑉 ≤ 0.05 Å/ns. However, for the other pulling protocols, 
the critical pulling velocity 𝑉𝑐  after which the deformation becomes reversible might vary, as the 
response of 〈𝑊〉 on 𝑉 is nonlinear and strongly depends on the pulling protocol. Importantly, we 
find from Fig. 9 that 〈𝑊〉 for the DNA–daunomycin complex is always higher than that for the 
bare B-DNA for both the pulling protocols, at each pulling velocity. Therefore, our claim that 
DNA intercalator enhances the mechanical strength of dsDNA is robust, considering the five 
different pulling protocols, the multiple pulling velocities and the two intercalators studied in this 
work.           
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FIG. 9. Pulling velocity dependence of the average cumulative work done, 〈𝑊〉, for the SE pulling 
(a) and the MU (b) protocols. The SE pulling and the MU protocols are described in Figs. 2(a) and 
2(e), respectively. In each plot, 〈𝑊〉 profiles at two different pulling velocities (𝑉 = 0.2 Å/ns and 
1 Å/ns) are provided for both the DNA–daunomycin complex and the bare B-DNA. In (a), 〈𝑊〉 
profile for the DNA–daunomycin complex at a very small 𝑉 (= 0.05 Å/ns) is also plotted.  
Interestingly, this 〈𝑊〉 profile is almost like that at 𝑉 = 0.2 Å/ns.  
V. CONCLUSIONS 
Using both equilibrium MD and SMD simulations, we show that DNA intercalator strongly 
modifies the mechanical properties of DNA. This might have serious consequences for active 
biological processes, such as DNA repair, transcription and replication. Particularly, we find that 
the stretch modulus, γ, of the DNA significantly increases upon intercalation of daunomycin or 
ethidium. The observed increase in γ upon drug intercalation is in accord with recent experimental 
studies.23,24 In contrast, we find that the persistence length 𝑙𝑝 and the bending modulus κ of dsDNA 
decrease upon intercalation of daunomycin or ethidium. There results for the change in 𝑙𝑝 of DNA 
upon drug intercalations reported in various experimental studies disagree with each other, as 
discussed in Ref. 13. So, there is a scope for simulation studies to understand this discrepancy in 
the measured elastic moduli of different intercalated drug–DNA complexes.24-26 
From all the pulling protocols, we find that dsDNA stretching and melting (dissociation of the two 
DNA strands) in the presence of either one of the intercalators become difficult because of the 
enhanced stability of intra-base-pair hydrogen bonds that arises from the π-stacking interaction 
between the phenyl rings of the DNA bases and of the intercalator. We also observe that the effect 
of DNA intercalators on the structure of DNA is local. Overall, our study is a significant step 
towards a quantitative understanding of the nanomechanics of DNA–ligand complexes and will 
be valuable for the DNA-targeted therapeutics research.5 For designing better drugs for 
chemotherapy, our study calls for further in vivo investigations to understand the relation of the 
enhanced mechanical strength of DNA in presence of intercalated anticancer drug found in this 
study to its biological functions.   
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It would be interesting to study the thermal denaturation70 of dsDNA in the presence and absence 
of intercalators and compare the temperature-induced melting pathways to the force-induced 
melting pathways obtained in this study by the various pulling protocols. Given that people have 
already started to use DNA as molecular wire in nanoelectronics, how intercalators modify DNA’s 
electrical properties71,72 is of technological and fundamental interest. Some of these aspects are 
currently under investigation in our group. 
SUPPLEMENTARY MATERIAL 
See supplementary material for figures S1–4. Rise and twist versus the base pair step for all the 
three complexes, analyses of the structural and elastic properties of the middle 6 base pairs of DNA 
for all the three complexes, and the instantaneous snapshots of the DNA–ethidium complex at 
various DNA-extensions for the OS3 pulling and the MU protocols are given. 
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Supplementary Material 
 
 
FIG. S1. Effect of an intercalator on DNA’s inter base pair rise and twist. Rise (a) and twist (b) as 
a function of the base pairs step (number) are plotted for the bare B-DNA and the two intercalated 
drug–DNA complexes. The error bar for each step of base pairs in each plot is the standard 
deviation of 2500 data points obtained from the last 50 ns of simulation time. For each drug 
intercalated complex, rise for the step of the 6–7 base pairs is ~3.5 Å more than that of the bare B-
DNA, as an intercalator is present between these two base pairs. Otherwise, the rise is the same 
both in the presence and absence of an intercalator. Twist for the step of the 6–7 base pairs of the 
DNA–daunomycin (= 29°) and DNA–ethidium (= 7°) complexes are much less than that of the B-
DNA (= 36°). Twist of DNA in the presence of an intercalated drug differs from that of the bare 
B-DNA maximum up to 3 base pairs on either side of the intercalation site. This represents local 
unwinding of the DNA double helix structure in the presence of an intercalator, which is more 
significant for ethidium than daunomycin. 
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FIG. S2. Comparison of structure and elastic properties of the middle 6 base-pairs of DNA (marked 
within the rectangle) for the bare B-DNA (a), the DNA–daunomycin (b), and the DNA–ethidium 
(c) from equilibrium simulations. The representations and colors are the same as shown in Fig. 1 
in the main text. Stretch modulus, γ, and persistence length, 𝑙𝑃, (as well as bending rigidity κ) for 
each system given in Table II in the main text are calculated from the normalized probability 
distributions of DNA contour length (d) and bending angle (e), respectively. See the calculation 
details in the main text. The distributions for each system are obtained from the last 50 ns of 200 
ns long simulation. 
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FIG. S3. (i–x) The instantaneous snapshots for shearing of the DNA–ethidium complex by the 
OS3 pulling protocol are shown at various DNA-extensions as pointed in the force–extension plot 
in Fig. 8(a) in the main text. The representation and color coding in each snapshot are the same as 
described in Fig. 1 in the main text.  
 
 
 
S4 
 
 
 
 
 
 
 
 
 
 
 
FIG. S4. (i–viii) The instantaneous snapshots for tearing of the DNA–ethidium complex by the 
MU protocol are shown at various DNA-extensions as pointed in the force–extension plot in Fig. 
8(b) in the main text. The representation and color coding in each snapshot are the same as 
described in Fig. 1 in the main text.  
